Skip to content

Intra Uterine Growth Restriction

Intra Uterine Growth Restriction. Minimum Required Evidence-based Care and Neonatal Prognosis: Impact of Healthcare Pathways

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03866863
Acronym
IUGR
Enrollment
31052
Registered
2019-03-07
Start date
2018-09-01
Completion date
2019-04-30
Last updated
2019-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine Growth Restriction

Brief summary

Intrauterine growth restriction (IUGR) is associated with an increase in perinatal mortality and morbidity, as well as longer-term neurological, cognitive, cardiovascular and endocrine complications. In Europe, about 400,000 pregnancies per year are complicated by IUGR. However, antenatal diagnosis seems insufficient in clinical practice, making it impossible to recognize up to 75% of foetuses with IUGR. At a time when the use of good clinical practice has demonstrated a significant improvement in neonatal survival without severe morbidity, foetuses with IUGR are less likely to receive optimal care. Our hypothesis is that the rate of IUGR diagnosed underestimates the rate of actual IUGR.

Interventions

OTHERIntrauterine growth restriction (IUGR)

Collection of number of patient's diagnosed with IUGR as defined in accordance with the consensus-based definition for early and late IUGR : birthweight \< 3rd centile using French AUDIPOG curves adjusted for term and sex or estimated fetal weight \< 10th centile combined with umbilical artery pulsatility index \> 95th centile or breakage of growth.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All birth more than 24 + 0 weeks of amenorrhea at the maternity ward of the hospital Femme-Mère-Enfant * from 1st of january 2011 to 31 december 2017.

Exclusion criteria

* Infants born out of the hospital and secondarily hospitalized in the hospital Femme-Mère-Enfant . * Multiple pregnancies, * children with congenital fetal anomalies * pregnancies without first trimester ultrasound (to date the pregnancy)

Design outcomes

Primary

MeasureTime frameDescription
Number of patients diagnosed with Intrauterine growth restrictionBetween 2011 and 2017IUGR was defined in accordance with the consensus-based definition for early and late IUGR : birthweight \< 3rd centile using French AUDIPOG curves adjusted for term and sex or estimated fetal weight \< 10th centile combined with umbilical artery pulsatility index \> 95th centile or breakage of growth.

Countries

France

Contacts

Primary ContactMuriel DORET, Prof.
muriel.doret-dion@chu-lyon.fr4 27 85 51 70

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026